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Abstract
Obesity is associated with altered fatty acid profiles, reduced fertility, and assisted reproductive technology (ART) success. The effects
of palmitic acid (PA), oleic acid (OA), and their combination on mouse preimplantation development, endoplasmic reticulum (ER)
stress pathway gene expression, lipid droplet formation, and mitochondrial reactive oxygen species (ROS) were characterized. Twocell stage mouse embryos collected from superovulated and mated CD1 females were placed into culture with KSOMaa medium, or
PA alone or in combination with OA for 46 h. PA significantly reduced blastocyst development in a concentration-dependent manner,
which was prevented by co-treatment with OA. PA and OA levels in mouse reproductive tracts were assessed by liquid chromatography coupled to mass spectrometry (LC-MS). LC-MS indicated higher concentrations of PA in the mouse oviduct than the uterus.
Transcript analysis revealed that PA alone groups had increased ER stress pathway (ATF3, CHOP, and XBP1 splicing) mRNAs,
which was alleviated by OA co-treatment. OA co-treatment significantly increased lipid droplet accumulation and significantly
decreased mitochondrial ROS from PA treatment alone. PA treatment for only 24 h significantly reduced its impact on blastocyst
development from the 2-cell stage. Thus, PA affects ER stress pathway gene expression, lipid droplet accumulation, and mitochondrial
ROS in treated preimplantation embryos. These mechanisms may serve to offset free fatty acid exposure effects on preimplantation
development, but their protective ability may be overwhelmed by elevated PA.
Keywords Preimplantation development . Free fatty acids . ER stress . Blastocyst . Fertility

Introduction
Global obesity is increasing rapidy [1]. In 2017, Statistics
Canada reported that 1.87 million and 1.61 million women

of reproductive age (18–49 years old) were overweight or
obese, respectively [2]. Obesity increases disease risk and infertility in both males [3] and females [4]. Given that obese
women have greater difficulty conceiving, they are more
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likely to seek fertility treatments and make use of assisted
reproductive technologies (ARTs). Unfortunately, studies report substantially poorer outcomes for obese women seeking
the assistance of fertility treatments [5–8]. Obese women display decreased responses to gonadotropins used for ovarian
stimulation and thus require higher doses of hormones when
undergoing ovarian stimulation [7, 9]. With increasing body
mass index (BMI), the number of oocytes successfully collected decreases [9, 10]. Thus, regardless of increased gonadotropin doses, obesity is associated with significantly greater
risk of unsuccessful ovarian stimulation cycles [7]. In vitro
fertilization (IVF) or intracytoplasmic sperm injection (ICSI)
in obese women does not affect their ability to become clinically pregnant [8]; however, obese women are at a higher risk
for early and recurrent pregnancy loss [9, 11] and miscarriage
[8]. During pregnancy, obese women have a higher prevalence of gestational diabetes [11]. Additionally, live birth frequencies are reduced with obesity [7]. The mechanisms underlying the negative direct effects of obesity on reproduction
are not fully understood and must be investigated to assist this
rapidly growing patient population.
Non-esterified fatty acids (NEFAs) are free fatty acid
(FFA) molecules found primarily bound to albumin in circulation [12]. High BMI is associated with elevated NEFA
levels in vivo [13]. Palmitic acid (16:0, PA) is the most abundant NEFA in circulation [14], and in the Western diet [15].
Oleic acid (18:1, OA) is the most abundant monounsaturated
NEFA in human serum [14]. Concentrations of free PA and
OA are between 50 and 70 μM in human follicular fluid and
increase in obese women [16]. Although PA concentrations in
the human female reproductive tract remain unknown, its
presence in serum and follicular fluid suggests that PA and
OA are the primary FFAs that embryos are exposed to during
preimplantation development. Although PA and OA structurally differ by only two carbons and a double bond, these FFAs
have very different metabolic fates [17]. PA, but not OA, is
associated with higher diabetes risk [18]. PA displays greater
incorporation into phospholipids, and increased lipogenesis,
increased beta oxidation, and reduced oxidative phosphorylation than OA does [17].
Exposure to maternal high-fat diet in vivo significantly
lowers development of mouse embryos to the blastocyst stage
[19]. In mice, transfer of blastocysts from mothers fed a highfat diet into control normal weight recipients still results in
fetal growth restriction and brain developmental abnormalities, indicating that the underlying origin of the problem occurs due to exposure to a high-fat environment during gametogenesis and/or preimplantation development [19]. Increased
FFAs in human follicular fluid are correlated with poor
cumulus-oocyte-complex (COC) quality [20]. Treatment of
bovine COCs with FFAs impairs blastocyst development;
however, rescue by the unfolded protein response (UPR)/endoplasmic reticulum (ER) stress pathway inhibitor salubrinal
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identified UPR activation as a major contributor to FFAdependent developmental decreases [21]. Studies conducted
over the past decade have indicated that the preimplantation
embryo is armed with several key stress response mechanisms
that, in part, offset the deleterious effects of stress on early
development (for review see [22, 23]). Most notably, these
are the ER stress pathways, which oversee the unfolded protein response (UPR) and activate stress-responsive gene expression patterns in an attempt to allow the early embryo to
effectively adapt to and survive both external and internal
stressors [22, 23]. Studies, including ours, have demonstrated
the presence and action of ER stress pathways throughout
preimplantation development [24–27]. To date, however,
studies have not investigated the influences of free fatty acid
treatment, i.e., PA and OA on ER stress pathway constituents,
and we postulate that differential responses to PA and OA
treatment should occur during preimplantation development.
Investigating the direct effects of FFAs on preimplantation
embryos in vitro is required to define the mechanistic consequences of exposure to PA and OA, in isolation and in combination, on mammalian preimplantation embryo development in general. We must also learn how the high-fat environment in an obese patient affects preimplantation development.
Ultimately, research should inform how the in vitro culture
environment can be modified to alleviate deleterious effects
of FFA exposure on not only early development but also its
longer-term effects on pregnancy, on fetal development, and
throughout life. In this study, we report outcomes from experiments in which 2-cell stage mouse embryos were treated with
increasing concentrations of PA or OA alone and in combination. We report the effects of these treatments on preimplantation development, ER stress pathway gene expression, lipid
droplet formation, and mitochondrial reactive oxygen species
(ROS) generation. In addition, we report PA and OA concentrations in the mouse oviduct and uterus. Our outcomes reveal
that the PA treatment reduces blastocyst development and
alters ER stress pathway transcript levels. OA co-treatment
with PA not only reverses PA effects on blastocyst development and ER stress transcript levels but also increases lipid
droplet formation and reduces mitochondrial stress. We conclude that preimplantation embryos do employ stress response
mechanisms to avoid deleterious effects of PA exposure, but
their protective ability may be overwhelmed by exposure to
elevated PA.

Materials and Methods
Animal Source and Ethics Approval
All experiments were performed using CD-1 mice from
Charles River Laboratories (Saint-Constant, QC). All mice
were handled according to the Canadian Council on Animal
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Care and Western University’s Animal Care and Use Policies
(protocol #: 2018-075 to Dr. Andrew J. Watson). Mice were
housed using conventional housing with a 12-h light/dark cycle and access to standard mouse chow ad libitum.

Liquid Chromatography Mass Spectrometry Analysis
of Oviduct and Uterine PA and OA
Oviduct and uterine concentrations of free PA and OA were
quantified using Ultra Performance Liquid Chromatography
(UPLC) coupled to quadrupole time of flight (QToF) mass
spectrometry. Pairs of ovaries and uterine horns were carefully
dissected free of visible fat, placed into cryovials, and frozen
over liquid nitrogen before storing at − 80 °C. Following
thawing, ovaries or uteri were weighed and 200 μL of acetonitrile containing labeled PA and OA (internal standards,
50 μg/mL each) was added to each sample. Samples were
homogenized and incubated on ice for 20 min. Samples were
then centrifuged at 20,800×g, and the clear supernatant was
transferred to a clean glass vial. Analytes were separated using
a Phenomenex Phenyl-Hexyl column, 2.1 × 100 mm, 1.7 μ
using a Waters Acquity UPLC (Milford, MA) maintained at
40 °C. The mobile phases consisted of water with 0.1% formic
acid (A) and acetonitrile with 0.1% formic acid (B) and were
pumped across the column at 0.5 mL/min. The gradient was as
follows: from 0 to 1.5 min, the gradient went from 80 B to
99% B and was held at 99% B from 1.5 to 2.0 min. The
column was reconditioned with 80% B for 1 min before
injecting the next sample. The mass spectrometer used was a
Waters Xevo G2-S QToF operated in negative ionization
mode with the following parameters: capillary voltage,
2 kV; cone voltage, 40 V; source temperature, 150 °C;
desolvation temperature, 500 °C; desolvation gas flow,
1000 L/h. Data were acquired using MSe in resolution mode
with a scan time of 0.05 s and a mass range of 50–1200 m/z.
The mass accuracy of the instrument was maintained by infusing leucine-enkephalin (1 ng/μL) as the lockspray, which
was acquired, every 10 s with a scan time of 0.3 s, which were
averaged over 3 scans.

Mouse Superovulation and Mating
Four- to six-week-old female CD-1 mice were intraperitoneally (IP) injected with 7.5 international units (IU) of pregnant
mare’s serum gonadotropin (PMSG, Merck Animal Health,
Canada) to stimulate follicular development. Forty-eight
hours later, these same females were IP injected with 7.5-IU
human chorionic gonadotropin (hCG, Merck Animal Health,
Canada) to stimulate ovulation. Immediately after hCG injection, each female was placed in a cage with a single male CD1 mouse (6–8 months of age) for mating overnight. The following morning, female mice were checked for presence of a
seminal plug. Forty-six hours post-injection (hpi) of hCG,
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female mice were euthanized by CO2 asphyxiation (standard
operating procedure) and had their oviducts removed and
flushed with room temperature M2 flushing medium
(Sigma-Aldrich, Oakville, ON) [28–30]. Flushed 2-cell stage
embryos were washed 3× in 50-μL drops of potassium simplex optimization medium with amino acids (KSOMaa
Evolve, Zenith Biotech, Canada). After washing, embryos
were distributed equally among experimental treatment
groups and cultured in 20-μL drops under mineral oil
(Zenith Biotech, Canada) at a density of 1 embryo per microliter for 46 h under a 5% CO2, 5% O2, and 90% N2 culture
atmosphere.

Free Fatty Acid Preparation and Embryo Culture
Essentially FFA-free bovine serum albumin (BSA, SigmaAldrich, Oakville ON) was added to phosphate buffered saline
(PBS) and dissolved overnight to create a 20% BSA solution.
This solution was filter sterilized and used downstream for
conjugation to PA (Sigma-Aldrich, Oakville ON) or OA
(Sigma-Aldrich, Oakville, ON). Stock PA and OA solutions
were prepared by solubilizing each FFA in RNAse-free water
and NaOH at 70 °C to create a 20-mM solution. This stock
sample was conjugated in a 2:1 molar ratio to BSA to create a
final 500-μM FFA solution that was stored at 4 °C.
Experiments were performed where 2-cell stage embryos
were cultured in FFA conjugated 2:1 to BSA in KSOMaa.

PA and OA Concentration Response and Treatment
Experiments
We first defined the concentration effects of PA and OA treatments alone on development of 2-cell stage embryos to the
blastocyst stage. The treatment concentration series for PA
consisted of 25, 50, and 100 μM, and for OA was 50, 100,
250, and 500 μM. For each experimental replicate and treatment group, twenty 2-cell embryos were placed into 20-μL
drops of the appropriate treatment medium covered by
embryo-grade mineral oil (Zenith Biotech, Canada).
Embryos were cultured under a 5% CO2, 5% O2, and 90%
N2 atmosphere at 37 °C for 46 h to assess progression to the
blastocyst stage.
Once effects of single PA and OA treatment on development was characterized, we proceeded with conducting single
treatment and PA and OA combination treatment experiments. Treatments included control (+ 1.5% BSA); 100-μM
PA alone; or 100-μM PA with either 50-; 100-, or 250-μM
OA in combination in KSOMaa. The BSA content was controlled between treatments using a 1.5% BSA in KSOMaa
control, which was prepared from the original 20% BSA solution. For each experimental replicate and treatment group,
twenty 2-cell embryos were placed into 20-μL drops of the
appropriate treatment medium covered by embryo-grade
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mineral oil (Zenith Biotech, Canada). Embryos were cultured
under a 5% CO2, 5% O2, and 90% N2 atmosphere at 37 °C for
46 h to assess progression to the blastocyst stage.
To assess the effect of PA treatment time on development
to the blastocyst stage, twenty 2-cell embryos were placed in
control media or 100-μM PA treatment media for 24-h culture, and then embryos were washed and placed into PA-free
control medium for either 24 or 48 additional hours of culture,
leaving the embryos in culture for a total of 48 and 72 h,
respectively. Blastocyst development was assessed at the
end of the 48- and 72-h culture periods.

Developmental Stage Analysis
At the end of each experimental replicate culture period, embryos were examined under a light-dissecting microscope.
The proportion of embryos at each stage of preimplantation
development was recorded. Embryos were classified as either
a blastocyst, morula (compacted embryo), 8-cell, 4-cell, 2cell, or degenerated embryo. Morulae were defined as embryos where distinct blastomeres could not be identified or counted, but no visible fluid-filled cavity was apparent. Blastocysts
were defined as any embryo with a visible fluid-filled cavity.
After developmental analysis, embryos were either snap frozen at − 80 °C for RNA extraction or fixed for future staining
and confocal microscopy.

RNA Extraction and Reverse Transcription
The ARCTURUS PicoPure RNA Isolation Kit (Life
Technologies, Burlington, ON) was used per the manufacturer
protocol to extract total RNA from pools of 20 preimplantation mouse embryos in each sample and replicate [30].
Exogenous luciferase mRNA (0.025 pg/embryo, Promega,
USA) was added for use as a reference standard gene when
analyzing mRNA quantities using the delta delta cycle threshold (2-△△Ct) method. To eliminate genomic DNA, DNase 1
(RNA-free DNase kit, Qiagen, Louisville, KY) was added in
an additional step. The VILO cDNA Synthesis Kit
(Invitrogen, Burlington, ON) was used according to the manufacturer protocol to reverse transcribe the extracted RNA into
cDNA. cDNA was diluted to 1 embryo/μL in PCR-grade
water.

XBP1 Spliced and Unspliced Transcript Detection
To confirm the effectiveness/quality of cDNA synthesis, polymerase chain reaction (PCR) was performed for H2A and
luciferase on each embryo reverse transcribed sample. Each
reaction included 2.5 μL of 10X PCR buffer, 0.75-μL MgCl2,
0.5-μL dNTPs, 0.1 μL each of the forward and reverse primer,
0.2-μL Taq polymerase, and 19.85-μL RNase-free water. The
cycling conditions for both H2A and luciferase were 94 °C for
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2 min, followed by 44 cycles of 94 °C for 30 s, 61 °C (H2A) or
59 °C (luciferase) for 30 s, 72 °C for 1 min, and a last step of
72 °C for 10 min. PCR products were run on a 2% agarose gel
for H2A/luciferase with ethidium bromide in TAE running
buffer at 100 V for 1 h, after which the gel was imaged. For
XBP1 mRNA transcript detection, cycling conditions were
94 °C for 2 min, followed by 45 cycles of 94 °C for 30 s,
61 °C for 30 s, 72 °C for 1 min, and a last step of 72 °C for
10 min. XBP1 PCR products were run on a 4% agarose gel
with TBE running buffer at 60 V for 3 h. Positive controls
contained cDNA from embryos that were treated with the
potent and reliable ER stress inducer tunicamyin [31], while
negative controls included RNase-free water in place of
cDNA. Splicing of XBP1 was quantified using the ImageJ
software on three biological replicates.

Quantitative RT-PCR Assessment of ATF3, CHOP, and
ATF6, Transcripts
Quantitative RT-PCR was performed using Taqman primer
probes (Invitrogen, Canada) for target genes in a 384-well plate.
Master mix (MM) of TaqMan Gene Expression Mastermix
(volume = 0.5 × total volume (V)), TaqMan primer probe (volume = 0.05 × V), and RNase-free water (volume = 0.4 × V)
were prepared and 62.7 μL aliquoted into Eppendorf tubes, to
which 3.3 μL (equivalent to 1 embryo/μL) of embryo cDNA
was added. This mixture of master mix and cDNA was
vortexed, and 20 μL was added in triplicate wells to the PCR
plate. For each experimental series, a negative no transcript
control was included, where RNase-free water replaced the
cDNA. Using a BioRad CFX384 Touch™ Real-Time PCR
Detection System, quantitative RT-PCR (qPCR) was run according to the following conditions: 5 min at 95 °C (AmpliTaq
GOLD DNA polymerase activation step), followed by 50 cycles of 15 s at 95 °C (denaturation) and 1 min at 60 °C (annealing and extension). To assess ER stress, primer probes for
ATF3 (Mm00476032_m1), CHOP (Mm01135937_g1
Ddit3), and ATF6 (Mm01295317_m1 Atf6) were used. Three
biological replicates were assessed for each gene, for each treatment, and for each experimental replicate.

BODIPY 493/503 Staining to Assess Embryo Lipid
Droplet Accumulation
After the 46-h culture treatment period, embryos from treatment and control were placed in 2% paraformaldehyde in PBS
for 30 min for fixing. They were then washed 3X in PBS and
stored at 4 °C. BODIPY (ThermoFisher Scientific,
Mississauga, ON) was solubilized in DMSO to a concentration of 2.5 mg/mL to create a stock solution, and an aliquot
was diluted to 20 μg/mL using the KSOMaa medium.
Embryos from all treatment groups, except the negative control, were placed in 20-μL drops of BODIPY solution covered
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in embryo-grade mineral oil for 1 h at room temperature.
Embryos were then washed 3× in PBS and added to 10-μL
drops of PBS covered in mineral oil in a glass-bottom dish. An
independent group of embryos exposed to OA at varying concentrations was used to set the laser intensity (Alexa Fluor
488). Embryos were imaged using confocal microscopy
(Zeiss LSM800 microscope) at × 10 magnification. Z-stacks
were imaged in 5-μm slices. Images were processed using the
FIJI and Ilastik software [32]. Within a group, each embryo
was defined as a biological replicate. The fluorescence intensity of each individual embryo in each treatment group was
quantified to determine mean fluorescence within a treatment
group using the Ilastik software.

Reprod. Sci. (2020) 27:2038–2051

same statistical analyses were used when analyzing the number of embryos arrested at different stages of development
with the FFA treatments. Using cycle threshold values from
qRT-PCR, relative amounts of mRNA were quantified using
the delta delta cycle threshold (2-△△Ct) method followed by
one-way ANOVA and Tukey’s multiple comparisons tests.
Data analysis for BODIPY and MitoSox™ Red outcomes
included applying one-way ANOVA with Tukey’s multiple
comparisons tests. For all tests, p values of less than or equal
to 0.05 were considered significantly different from one
another.

Results
MitoSox™ Red Superoxide Stain
MitoSox™ Red mitochondrial superoxide indicator (Life
Technologies, Burlington, ON) was solubilized in DMSO
and diluted using KSOMaa to a concentration of 5 μM.
Culture dishes were prepared with 20-μL drops of this solution covered in embryo-grade mineral oil. Live embryos were
incubated in this solution for 1 h at 37 °C, 5% O2, 5% CO2,
and 90% N2. A no-MitoSox™ Red negative control was also
included. Embryos were then washed 3× in KSOMaa and
added to 10-μL drops of KSOMaa in a glass-bottom dish for
imaging by confocal microscopy (Zeiss LSM800 microscope)
at × 10 magnification. An independent group of embryos exposed to 100-μM PA treatment was used to set the confocal
laser intensity (Alexa Fluor 568). Z-stacks were imaged in
5-μm slices. Images were processed using the FIJI and
Ilastik software [32]. Within a group, each embryo was a
biological replicate. The fluorescence intensity of each individual embryo in each treatment group was quantified to determine mean fluorescence within a treatment group using the
Ilastik software.

Statistical Analyses
GraphPad PRISM 8 (https://www.graphpad.com/scientificsoftware/prism/) was employed to perform statistical
analyses. For analysis of tissue concentrations of PA and
OA by mass spectrometry, a two-way analysis of variance
(ANOVA) was performed with main factors of age and tissue
type and means compared by using Tukey’s multiple comparisons tests. For all subsequent experiments, a minimum of
three biological replicates was conducted. For imaging studies, a biological replicate was defined as a single embryo
within a treatment. However, for assessments of developmental stage and mRNA abundance through qPCR, a biological
replicate consisted of a single pool of 20 embryos within a
treatment group. Blastocyst development was analyzed using
a one-way ANOVA test, and means were compared to one
another by an ad hoc Tukey’s multiple comparisons test. The

PA and OA Concentrations in Mouse Oviduct and
Uterus
Table 1 shows the mean ± standard error (SE) of the mean
concentrations of PA and OA that were detected using liquid
chromatography mass spectrometry (LC-MS) in whole mouse
oviduct (4-week-old mice, n = 9; 8-month-old mice, n = 12)
and uterine (4-week-old mice, n = 10; 8-month-old mice, n =
12) lysates. Values were corrected for tissue weight; pairs of
oviducts ranged from 5.1 to 13.3 mg, while uteri ranged from
40.1 to 142.1 mg. Older mice displayed higher oviduct and
uterine weights than 4-week-old mice. In the two-way
ANOVA for PA, there was no effect of age or interaction;
however, there was a significant effect of tissue type.
Oviducts had significantly higher (p < 0.001) concentrations
of PA than uteri. PA concentrations were significantly higher
(p < 0.05) than OA concentrations in oviducts and uteri for
both age groups. In contrast, for OA, there was a significant
interaction of age by tissue (p < 0.02), such that young oviducts had lower OA concentrations than older oviducts, or
young or older uteri. There were also significant effects of
age (p < 0.01) and tissue (p < 0.001) with uteri having higher
average OA concentrations compared with oviducts (Table 1).

Concentration-Responsive Effects of PA and OA
Treatment on Mouse Preimplantation Development
The concentration-responsive effects of treating 2-cell stage
mouse embryos with increasing doses of PA and OA are
shown in Fig. 1. OA concentration, at all doses (46 h of treatment), did not have a significant (p > 0.05) effect on the progression of treated embryos to the blastocyst stage (Fig. 1a).
PA treatment in contrast resulted in a significant decline
(p < 0.05) in the progression to the blastocyst stage for concentrations over 25 μM (Fig. 1b). This result was accompanied by a corresponding increase in the proportion of early
cleavage-stage embryos observed in PA treatment concentrations greater than 50 μM (data not shown). Embryos treated

Reprod. Sci. (2020) 27:2038–2051

2043

Table 1 Palmitic acid and oleic
acid concentrations in mouse
oviduct and uterus

Palmitic acid (μM)
Mouse groups

Oviduct

4-week CD1

377.6 ± 33.2(9)

8-month CD1
Combined values

Oleic acid (μM)
Uterus

Oviduct

192.8 ± 21.6(10)

(12)

18.0 ± 4.4(9)c

(12)

404.9 ± 33.2
393.2 ± 23.3(21)a*

Uterus

(12)d

145.1 ± 8.9
166.8 ± 11.9(22)b§

44.3 ± 3.2
33.0 ± 2.4(21)*

51.0 ± 6.6(10)d
51.8 ± 4.2(12)d
51.4 ± 3.7(22)§

N values in brackets for each group
All values represent mean ± SE
a,b

Within PA, superscripts denote significant differences between tissues, p < 0.001

c,d

Within OA, superscripts denote an age by tissue interaction, p < 0.02

*

Within oviducts, PA is higher than OA, p < 0.001

§

Within uteri, PA is higher than OA, p < 0.001

a

b

Blastocysts (%)

100

a

ab

80
60

b

40
c

20
0
0

25

50

100

Palmitic Acid A (µM)

Blastocysts (%)

c

100
80

a

ad

60
40

cd

20

b

0
0

PA

wash48 wash72

Treatment
Fig. 1 Concentration-responsive effects of PA and OA on blastocyst
development. The percentage of blastocysts after 46-h culture in
increasing concentrations of a OA or b PA. Treatment of 2-cell
embryos in 1.5% BSA and at all OA doses did not significantly affect
development to the blastocyst stage (a, p > 0.05, n = 3). In contrast,
treatment with concentrations of PA over 25 μM resulted in a
significant decline in development to the blastocyst stage (b, p < 0.05,
n = 3). c Effects of 24-h treatment with 100-μM PA followed by culture in
PA-free control medium for 24 h (wash48 h) and 48 h (wash72 h) after

treatment on development from the 2-cell stage. Twenty-four-hour PA
treatment (wash48) at the 2-cell stage did not reduce blastocyst
development as severely as 46-h PA treatment (PA, c, n = 3–8). In fact,
2 cell embryos treated for 24 h with 100-μM PA and then placed into
control medium for 48 h (wash72) displayed an equivalent level of
development to the blastocyst stage as untreated controls (c). Bars
represent the mean percentage of embryos at the blastocyst stage +
standard deviation (SD) (a, b, c). Bars with p values < 0.05 are
statistically significant from one another
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with PA dose higher than 50 μM increasingly displayed cell
fragmentation and unequal blastomere size (Fig. 2f).
However, embryos exposed to OA alone displayed normal
morphological characteristics expected for mouse preimplantation embryos at all stages (data not shown). In contrast, 2cell embryos treated with 100-μM PA for 24 h only and then
placed into PA-free control medium for 24 h (for a total of
48 h of culture) displayed significantly (p < 0.05) higher development to the blastocyst stage than that displayed by 46-h
PA-treated 2-cell embryos (Fig. 1c, wash48). Furthermore,
when 24-h PA-treated 2-cell embryos were cultured in normal
control medium for 48 h after treatment (for a total treatment
and culture time of 72 h), blastocyst development was no
longer significantly different from control levels of development (Fig. 1c, wash72). Since 100-μM PA-treated embryos
displayed a capacity to recover from treatment, we adopted
this PA concentration level as standard for all subsequent experiments. Controls for BSA content (BSA = 1.5%; 0 =
1 mg/ml BSA, Fig. 1a) demonstrated that the BSA content
of the medium did not adversely affect development of treated
2-cell embryos to the blastocyst stage.

Effect of PA and OA Co-Treatment on Mouse
Preimplantation Development
To characterize the effects of combined treatment, 2-cell stage
embryos were placed into culture in either control medium;
medium with 100-μM PA alone; or medium (100-μM PA) in
combination with 50-, 100-, or 250-μM OA for 46 h. PA
alone significantly reduced development to the blastocyst
stage (p < 0.05, Fig. 2d), with a corresponding significant increase in the proportion of early cleavage-stage embryos undergoing a developmental arrest before the morula stage
(p < 0.05, Fig. 2a–c). The proportion of morula-stage embryos
did not differ between treatments (p > 0.05, Fig. 2c). In complete contrast to the PA alone treatment results, OA cotreatment at all doses (50–250-μM concentrations (p < 0.05,
Fig. 2d)) offsets the PA-induced significant decline in the
development of 2-cell stage embryos to the blastocyst stage
in vitro. Figure 2f displays the typical morphology of embryos
treated with 100-μM PA compared with untreated controls
(Fig. 2e) and to that of 2-cell stage embryos co-cultured in
100-μM PA with all OA concentrations (Fig. 2g, PA+OA).

Effects of PA and OA on Preimplantation Embryo ER
Stress Pathway Transcripts
We next characterized the effects of PA and OA treatment on
preimplantation development ER stress pathways. To do this,
we characterized the effect of 100-μM PA treatment alone and
PA and OA combination treatment on transcript levels of
markers representing all three main ER stress pathways.
ATF3 and CHOP mRNA levels were not significantly
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affected by OA treatment at any dose (Fig. 3a and b).
However, in embryos treated with 100-μM PA alone, ATF3
transcript abundance increased significantly (p < 0.05) to over
15 fold that of control, and CHOP transcript abundance was
also significantly (p < 0.05) increased and approached 5-fold
greater levels than controls (Fig. 4a and b). In contrast, OA cotreatment at all doses alleviated the PA-induced increase in
CHOP and ATF3 mRNA levels (Fig. 4a and b).
Interestingly, PA treatment (100 μM) alone or in combination
with OA did not significantly affect the relative levels of
ATF6 mRNAs across all groups, suggesting that this arm of
the UPR may not be influenced by FFA exposure during
mouse preimplantation development (Fig. 4c). Investigation
of the IRE1 arm of the ER stress pathway required us to
measure changes in the proportion of XBP1 spliced and
unspliced mRNAs. XBP1 is downstream of IRE1 pathway
activation, and its activation is dependent upon transcript
splicing, with spliced transcript representing activated XBP1
that serves as a nuclear transcription factor upon activation of
ER stress response. Treatment with 100-μM PA significantly
(p < 0.05) increased in XBP1 mRNA splicing (Fig. 5A–C,
three separate experimental replicates displayed) relative to
controls. In contrast, XBP1 mRNA splicing was significantly
reduced (p < 0.05) when co-treatment with all OA concentrations was employed (Fig. 5D), while tunicamycin (an ER
stress activator)-treated positive (+) controls displayed a significant increase in spliced XBP1 (Fig. 5D).

Effects of OA and PA Treatment on Preimplantation
Embryo Lipid Droplet Abundance
Next, the influence of FFA treatment on lipid droplet (LD)
accumulation in mouse preimplantation embryos was characterized. Relative to embryos exposed to control media, OA
treatment alone (100 μM) significantly increased (p < 0.05,
Fig. 6Ab, Bb, and C) LD content. However, PA treatment
(100 μM) alone did not significantly affect LD content
(p > 0.05, Fig. 6Ac, Bc, and C). Co-treatment with 50-μM
OA (Fig. 6Ad, Bd, and C) also did not significantly alter LD
levels from that observed for controls (Fig. 6Aa, Ba, and C),
PA alone (Fig. 6Ac, Bc, and C), or 100-μM OA-treated embryos (Fig. 6Ab, Bb, and C). However, OA concentrations of
100 and 250 μM in combination with PA (100 μM) significantly increased (p < 0.05, Fig. 6Ae, Be, Af, Bf, and C) LD
levels to 16 and 18 times greater than those of controls,
respectively.

Effects of OA and PA Treatment on Preimplantation
Embryo on Mitochondrial Superoxide Levels
We next characterized whether PA (100 μM) or OA cotreatment affected preimplantation mouse embryonic mitochondrial superoxide levels, by measuring MitoSox™
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Fig. 2 PA and OA co-treatment effects on blastocyst development. 2-cell
stage embryos were placed into culture in either control medium (n = 13);
100-μM PA alone (n = 13); or 100-μM PA in combination with 50- (n =
10), 100- (n = 11), or 250- (n = 12) μM OA. PA alone significantly
reduced (p < 0.05) development to the blastocyst stage (d), with a
corresponding significant increase in the proportion of early cleavagestage embryos undergoing a developmental arrest before the morula
stage (a–c). The proportion of morula did not differ significantly
between treatments (c). OA co-treatment at all doses (50–250-μM

concentrations; d) alleviated the significant decline in development of
PA-treated 2-cell stage embryos to the blastocyst stage. Treatment with
100-μM PA increased the proportion of embryos displaying cell
fragmentation and unequal blastomeres relative to controls (e controls; f
PA treated). Co-culture of 2-cell embryos in 100-μM PA with OA
resulted in improved embryo morphology (g). Bars represent the mean
percentage of embryos at each stage + SD. Bars with different letters are
statistically significant from one another. Scale bars are equal to 50 μm

Red fluorescence. Mitochondrial superoxide produced
by embryos exposed to 100-μM PA treatment alone
(Fig. 7Ab, Bb, and C) or in combination with 50-μM

OA (images not shown, Fig. 7C) did not differ significantly from untreated control embryos (Fig. 7Aa, Ba,
and C). Interestingly, we did observe that mitochondrial

a

Fig. 3 Effect of OA treatment on ER stress transcripts. The effects of 50–
500-μM OA treatment alone for 46 h on ATF3 and CHOP transcript
levels in mouse blastocysts. ATF3 and CHOP mRNA levels were not

b

significantly affected by OA treatment at any dose (a, b, p > 0.05. n = 3).
Bars represent mean fold change in mRNA abundance relative to the
control + SD
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a
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c

Fig. 4 Effect of PA and OA co-treatment on ER stress transcripts. The
effects of exposure to 100-μM PA treatment alone, and PA and OA
combination treatments for 46 h on transcript levels of marker mRNAs
representing ER stress pathways were assessed. In 100-μM PA-treated
embryos, ATF3 transcript abundance increased significantly (p < 0.05,
n = 3) to 15 fold the control levels, and CHOP transcript increased
significantly (p < 0.05, n = 3) to 5 fold the control levels (a, b). OA co-

treatment at all doses alleviated the PA-induced increases in CHOP and
ATF3 mRNA levels (a, b, p < 0.05, n = 3). PA treatment (100 μM) alone
or in combination with OA did not significantly affect the relative levels
of ATF6 mRNAs across all groups (c, p > 0.05, n = 3). Bars represent
mean fold change in mRNA abundance relative to the control + SD. Bars
with different letters are statistically significant from one another

superoxide levels were significantly lower (p < 0.05) in
embryos exposed to 100-μM PA in combination with
100-μM or 250-μM OA (Fig. 7Ac, Bc, and C). Thus,
OA treatment displayed an ability to reduce basal levels
and mitochondrial superoxide levels within in vitro cultured embryos.

PA at lower than reproductive tract tissue concentrations disrupts preimplantation development to the blastocyst stage and
is accompanied by elevated ER stress pathway transcript
levels. In contrast, treatment with OA up to 500 μM does
not significantly affect development of 2-cell stage mouse
embryos to the blastocyst stage; however, it increases LD
accumulation and reduces mitochondrial ROS in early embryos. Most importantly, the addition of OA as a co-treatment
with PA counters the negative developmental impact of PA
alone as well as its impact on ER stress transcript levels.
Collectively, our results suggest that mouse preimplantation
embryos are exquisitely sensitive to external FFA levels, especially for PA. The early embryo appears to respond to this
stress, as it does for many other stressors, in part, by

Discussion
We have discovered that mouse oviductal PA concentrations
are nearly twice as high as mouse uterine PA concentrations
and are much higher than OA concentrations in these tissues.
Treatment of 2-cell stage mouse embryos in vitro alone with

PA (µM): Lad
OA (µM):

0 100 100 100 100
0 0 50 100 250 -

+

d

a

b

c
Fig. 5 Effect of PA and OA co-treatment on XBP1 splicing. To
characterize effects to the IRE1 arm of the ER stress pathway, we
measured effects of PA alone or with OA on the relative levels of
spliced XBP1 mRNA. Treatment with 100-μM PA significantly (p <
0.05, n = 3) increased XBP1 mRNA splicing (A–D) relative to controls.
XBP1 mRNA splicing was significantly reduced (p < 0.05, n = 3) when

co-treatment with OA occurred (A–D). Controls included a no-cDNA
negative control (−) and tunicamycin-treated embryo positive control
(+). A–C represent three biological replicates. Bars in D represent mean
percentage of spliced XBP1 transcripts + SD. Bars with different letters
are statistically significant from one another
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Fig. 6 OA treatment increases lipid droplet levels. Compared with
control media (n = 14), OA treatment alone (100 μM, n = 12)
significantly increased (p < 0.05, Ab, Bb, C) LD content. PA treatment
(100 μM, n = 18) alone did not significantly affect (p > 0.05, Ac, Bc, C)
LD content. Co-treatment with 50-μM OA (n = 13, Ad, Bd, C) did not
significantly alter LD levels from control (Aa, Ba, C) or PA alone (Ac,
Bc, C). OA at 100 (n = 15) and 250 (n = 16) μM significantly increased

0

PA (µM):
OA (µM):

C

(p < 0.05, Ae, Be, Af, Bf, C) LD levels 16 and 18 times greater than
controls, respectively. Scale bars represent 100 μm. Bars in C represent
mean BODIPY 493/503 fluorescence per embryo + standard error (SE).
Data is presented in fluorescence units with background fluorescence
subtracted. Bars with different letters are statistically significant from
one another

100

100
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C

Aa

Ab

Ba

Bb

Fig. 7 OA reduces MitoSox Red Fluorescence. Mitochondrial
superoxide produced by embryos exposed to PA treatment alone
(100 μM, n = 28) (Ab, Bb, C) or in combination with 50-μM OA (n =
24, images not shown) did not differ significantly from untreated control
embryos (n = 19, Aa, Ba, C). Mitochondrial superoxide levels were
significantly lower in embryos exposed to 100-μM PA in combination

Ac

Ad

Ae

Bc
with 100-μM (n = 24, Ac, Bc, C) or 250-μM OA (n = 24, images not
shown). Bars in C represent mean MitoSox Red fluorescence per embryo
+ standard error (SE). Data are presented in fluorescence units with
background fluorescence subtracted. Bars with different letters are
statistically significant from one another. Scale bars represent 50 μm
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upregulating the ER stress pathways. However, PA levels
may exceed this adaptive capacity, resulting in impaired preimplantation development. Our results are especially poignant
for obese patients seeking fertility treatment, as they bring into
focus the possibility of an obesity-conditioned reproductive
tract actively suppressing preimplantation development and
consequently pregnancy. Research must identify approaches
in which the debilitating effects of PA exposure may be
alleviated.
The literature has established that PA and OA have differential effects in many tissues. PA is generally viewed as being
pro-apoptotic, while OA has beneficial and protective effects
against PA [15, 33, 34]. For example, a recent review reported
that PA is pro-inflammatory and induces ER stress [35].
However, the negative effects of PA can be overcome by
relatively lower concentrations of OA in many tissues, including hepatocytes and pancreatic β cells [35]. PA reduces insulin sensitivity in hepatocytes [15] and skeletal muscle [36],
and thereby contributes to the development of type 2 diabetes
mellitus (T2DM). Conversely, OA is protective against insulin resistance and T2DM [35]. PA dose-dependently increased
podocyte ROS production and apoptosis, suggesting its contribution to podocyte loss in the kidney and subsequent development of diabetic nephropathy [37]. When administered intraperitoneally, PA is linked to behavioral abnormalities, such
as anxiety-like symptoms in mice [38]. Studies indicate that
PA exerts its negative effects through a variety of mechanisms, including alterations to cellular membranes [39], ER
stress [34, 40–46], diacylglycerol (DAG) accumulation [47],
mitochondrial dysfunction, and ROS production [48, 49].
These effects, which are collectively called “lipotoxicity,” ultimately result in ER stress and subsequent apoptosis if the
stress is not alleviated.
ER stress occurs in response to an accumulation of unfolded or misfolded proteins in the ER. The UPR pathway is
activated in an attempt to alleviate this stress [50]. If unable
to establish homeostasis, the UPR results in apoptosis [51].
Differential effects of physiologically relevant doses of PA
and OA on ER stress were observed in hepatoma cells, where
PA induced ER stress and OA did not [42, 52]. In primary
neonatal cardiomyocytes, PA induced both ER stress and apoptosis, whereas OA alone did not [34]. In rat liver hepatoma
cells, 500-μM PA treatment induced ER stress and elevated
PERK and IRE1α phosphorylation, and XBP1 splicing upon
PA exposure [42]. Given the close relationship in other tissues
between PA exposure and ER stress activation [34, 35,
41–47], we assessed the UPR and ER stress pathways in our
embryos using RT-PCR for XBP1 splicing and quantitative
RT-PCR for CHOP, ATF3, and ATF6. Thus, in total, we
investigated the effects of PA and OA treatment on all three
arms of the UPR, with ATF3 and CHOP falling under the
PERK arm, XBP1 splicing a marker of the IRE1α arm, and
ATF6 falling under its own arm. As is consistent with
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previous studies [24–27, 34, 53], PA altered ER stress pathway transcripts but OA did not. However, a key limitation of
our outcomes, is that UPR and ER stress pathway members
are regulated via posttranslational modifications, such as
phosphorylation of PERK, IRE1, and ATF6. Protein phosphorylation can be assessed through western blotting; however, the low protein abundance in mouse preimplantation embryos makes these experiments technically challenging to successfully perform and requires large embryo pools to effectively apply. In addition, we cannot conclude that the changes
we have observed “cause” the developmental blockade observed following PA treatment. We are simply reporting key
observations made in embryo pools following 46 h of treatment. We believe that these observations are the first to indicate that exposure to elevated PA may affect ER stress pathway constituent expression and that the addition of OA significantly reverses that occurrence. There are many more experimental designs and time course experiments that must be
conducted to fully understand this outcome, and we are very
interested in pursuing outcomes to those stage-specific effects
in future experiments. Our results are consistent with the
growing conclusion that OA is protective against PA’s effects,
specifically in that it alleviates PA-induced ER stress in mouse
preimplantation embryos [22–27, 34].
A recent review by Fayezi et al. [54] outlined the most
likely mechanisms through which OA exerts its protective
effects. These included but were not limited to 1) altering
triacylglycerol (TAG) synthesis, 2) reducing oxidative stress,
and 3) altering energy production. Fatty acids (FAs), either
bound to albumin or contained in lipoproteins, are found extracellularly. Once released, FAs enter the cell where they are
conjugated to CoA [55]. A series of enzymatically catalyzed
reactions in the ER allows for the formation of DAGs, which
can then form TAGs [55, 56]. Conversion of DAG to TAG is
the final step of TAG formation and is catalyzed by diacylglycerol acyltransferase (DGAT) enzymes DGAT1 and
DGAT2 [56]. PA and OA differentially affect LD accumulation. Since OA is steatotic and causes lipid accumulation,
exposure to OA increases LD number [47, 54]. LDs are made
up of a phospholipid monolayer surrounding a neutral lipid
core mainly consisting of TAGs [55]. Piccolis et al. [44] reported that when human leukemia cells were exposed to PA, a
primary mechanism responsible for lipotoxicity was ER
stress, which was associated with an accumulation of PA
and DAGs in the cells. In cardiomyoblasts, PA treatment reduced LD levels, whereas OA increased LD accumulation
[47]. This decrease in LDs with PA treatment was not due to
a lower supply of neutral lipid, as more PA accumulated in the
cells than OA, and fatty acid oxidation was reduced with PA
exposure [47]. The investigators concluded that the reductions
in LDs with PA were due to PA storage as DAGs, whereas
OA is largely stored as TAGs [47]. Accumulation of PA in the
ER likely contributes to induction of ER stress, activation of
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the UPR, and apoptosis should the ER stress not be relieved.
In our study, OA, but not PA, induced lipid droplet accumulation in mouse preimplantation embryos. Inclusion of OA
concentrations equal to or higher than the 100-μM PA in coculture resulted in lipid droplet accumulation that was significantly higher than control, PA-only, or OA-only treated embryos. When quantified, there was no difference in BODIPY
fluorescence in PA-treated embryo from controls. This outcome seems reasonable, as we suggest the PA could be accumulating as DAGs and would not accumulate within LDs.
Collectively, our findings suggest that OA directs accumulation of TAGs within cytoplasmic lipid droplets during mouse
preimplantation development. Given the similarity of our outcomes to studies applied to other tissues, we suggest that there
is reasonable likelihood for common mechanistic events arising during preimplantation development.
Studies have established that PA treatment often results
in mitochondrial dysfunction [57–62]. To consider this effect in preimplantation embryos, mitochondrial superoxide
levels in embryos exposed to PA alone or in combination
with OA were quantified. When OA was added to skeletal
myotubes cultured in PA, the PA-induced increase in
MitoSox Red fluorescence was dampened. Interestingly,
in our study, the embryos cultured in control, PA alone, or
PA co-cultured with 50-μM OA did not vary in the levels of
detectable mitochondrial superoxide. Compared with these
groups, embryos co-cultured with PA and 100- or 250-μM
OA produced significantly less mitochondrial superoxide.
We propose that the 100-μM PA treatment we employed
was not enough to elevate mitochondrial ROS. Clearly,
however, elevated OA concentrations (100 or 250 μM) have
the capacity to reduce mitochondrial ROS levels even below
that of basal culture-induced levels. Thus, it is possible that
adding OA alone to the culture medium may be beneficial
for supporting preimplantation embryo mitochondrial function. However, the differences in mitochondrial superoxide
levels may not be indicative of mitochondrial superoxide
production.
Overall, our outcomes essentially mirror those observed
regarding PA and OA’s effects across many different tissues; however, the effect of PA and OA in the reproductive
tract, specifically during preimplantation embryo development, has not been extensively investigated and defined.
The timing of preimplantation embryo development is a
key measure of embryo developmental competence [62].
Developmental competence is also often assessed by embryo cell number [62]. Although we did not measure blastocyst cell number, the fact that embryos exposed to OA
alone or in combination with PA were able to reach the
blastocyst stage within a normal culture period is indicative
of developmental competence and likely capacity to initiate
a pregnancy. The significantly decreased progression
throughout preimplantation development that we observed
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following PA treatment is an ominous sign and is highly
suggestive of decreased embryo viability even if the blastocyst stage is reached. Additionally, morphological assessment of PA-treated embryos displayed uneven blastomeres
and cell fragmentation, both of which are signs of reduced
embryo developmental competence [62, 63]. These morphological changes did not occur with PA and OA co-treatment, suggesting that mouse embryos that were exposed to
OA may have greater adaptive ability. When PA treatment
time was reduced to 24 h, we observed normal development
to the blastocyst stage following 48 h of post-treatment
culture in control medium. This indicates that 24-h exposure to PA delayed the embryos’ development; however,
removal of PA and additional culture time allowed the embryos to overcome this delay. We believe this to be an
important finding, as it suggests that removing embryos
from a high fatty acid environment may improve their development. Further research must be conducted to investigate the underlying mechanisms controlling the developmental blockade resulting from PA treatment.
In conclusion our outcomes have revealed that PA treatment
reduces blastocyst development and alters ER stress pathway
transcript levels. OA co-treatment with PA not only limits PA
effects on blastocyst development and ER stress transcript
levels but also increases lipid droplet accumulation and reduces
mitochondrial stress. Thus, preimplantation embryos do employ stress response mechanisms to avoid the deleterious effects of PA exposure, but their protective ability may be
overwhelmed by elevated PA levels. This information is vital
to our understanding of the influence of obesity on human
fertility. Investigating the extent of OA’s protective effects
using different culture concentrations and times of exposure
could contribute to optimizing culture environments for all preimplantation embryo culture systems, including that of the
human.
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